ScholarIQanswers from OpenAlex

Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia

PaperCitations, authors & open-access status

Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia have?

ScholarIQcitation count

Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia has 65 citations in the OpenAlex counts ScholarIQ stores.

When was Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia published?

ScholarIQyear

Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia has 2013 year in the ScholarIQ index.

What is the open-access status of Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia?

ScholarIQoa status

Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia has hybrid oa status in the ScholarIQ index.

What is the DOI of Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia?

ScholarIQdoi

The DOI for Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia is on the source record.

What is the PMID of Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia?

ScholarIQpmid

The PMID for Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia is on the source record.

What is the OpenAlex record for Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia?

ScholarIQopenalex

The OpenAlex for Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial